Involving patients more meaningfully in the industry's activities means getting more serious about their emotional wellbeing.
Julian Upton
Advertisement
Julian Upton is the European Editor of Pharmaceutical Executive and Editor of Pharm Exec Global Digest. He can be reached at jupton@advanstar.com.
Articles by Julian Upton
BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
Q&A explores the evolution of the patient-centric supply chain and how it's poised to impact the clinical trials landscape.
Advertisement
Latest Updated Articles
The Emergence of the Patient-Centric Supply ChainPublished: October 1st 2017 | Updated:
BMS and Biomarker Research: An Interview with Saurabh SahaPublished: May 1st 2018 | Updated:
- Engaging with Emotions: Patients as Partners
Published: February 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
3
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
4
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
